SciThera
San Diego, United States · $26.0M raised
- Headquarters
- San Diego, California
- Business Model
- B2B
- Website
- scithera.bio
- Total Funding
- $26.0M
- Last Round
- $26.0M SeedJan 2025
- Rounds
- 1
About
SciThera, Inc. is a San Diego, California-based biotechnology company focused on discovering and developing novel antibody-based therapeutics, including antibody-drug conjugates, for the treatment of cancer. According to an SEC filing by Inhibrx, SciThera is a newly formed biotechnology company that focuses on antibody-based molecules and has entered into a licensing agreement with Inhibrx. SciThera is backed by venture capital firm Venrock and led by CEO Brendan Eckelman.
Summary
SciThera is a Biotech company based in San Diego, United States. It has raised $26.0M in total across 1 round, most recently a $26.0M Seed round in Jan 2025. Investors include Venrock.
Funding History
Jan 2025
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/scithera"><img src="https://indexed.vc/api/badge/company/scithera" alt="SciThera on Indexed.vc" width="260" height="76" /></a>